ClinicalTrials.gov
ClinicalTrials.gov Menu

Cardiovascular Changes and Changes in Tissue Oxygenation During Early Postoperative Mobilization in Total Hip Arthroplasty (THA) Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01089946
Recruitment Status : Completed
First Posted : March 19, 2010
Last Update Posted : October 10, 2012
Sponsor:
Information provided by (Responsible Party):
Oeivind Jans, Rigshospitalet, Denmark

Brief Summary:
The purpose of this study is to investigate the cardiovascular changes during early postoperative mobilization of hip arthroplasty patients.

Condition or disease
Arthroplasty

Study Type : Observational
Actual Enrollment : 26 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Cardiovascular Changes and Changes in Tissue Oxygenation During Early Postoperative Mobilization After Primary Total Hip Arthroplasty
Study Start Date : March 2010
Actual Primary Completion Date : June 2010



Primary Outcome Measures :
  1. Orthostatic intolerance [ Time Frame: 6 and 24 hours postoperative ]

Secondary Outcome Measures :
  1. Orthostatic hypotension [ Time Frame: 6 and 24 hours postoperative ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients undergoing primary THA.
Criteria

Inclusion Criteria:

  • Age > 18 years
  • Primary THA

Exclusion Criteria:

  • Alcoholism
  • Known orthostatic hypotension
  • Daily use of anxiolytic medication

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01089946


Locations
Denmark
Hørsholm Hospital
Hørsholm, Denmark
Sponsors and Collaborators
Rigshospitalet, Denmark
Investigators
Principal Investigator: Oeivind Jans, M.D. Rigshospitalet, Denmark

Publications of Results:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Oeivind Jans, M.D, Research Fellow, Rigshospitalet, Denmark
ClinicalTrials.gov Identifier: NCT01089946     History of Changes
Other Study ID Numbers: RH-4074
First Posted: March 19, 2010    Key Record Dates
Last Update Posted: October 10, 2012
Last Verified: October 2012

Keywords provided by Oeivind Jans, Rigshospitalet, Denmark:
Mobilization
Hip arthroplasty
cardiovascular